Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C
Contributeurs/tricesSgier, C.; Mullhaupt, B.; Gerlach, T.; Moradpour, D.; Negro, Francesco; Male, P. J.; Heim, M. H.; Malinverni, R.; Cerny, A.; Dufour, Jean-François
Publié dansJournal of viral hepatitis, vol. 17, no. 12, p. 845-850
Date de publication2010
Résumé
Mots-clés
- Alanine Transaminase/blood
- Antiviral Agents/*therapeutic use
- Apoptosis
- Cohort Studies
- Hepacivirus/*drug effects/genetics/physiology
- Hepatitis C, Chronic/*drug therapy/virology
- Hepatocytes/physiology
- Humans
- Keratin-18/*blood
- RNA, Viral/blood
- Recurrence
- Switzerland
- Treatment Outcome
- Viral Load/*drug effects
- Viremia/drug therapy/virology
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
SGIER, C. et al. Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. In: Journal of viral hepatitis, 2010, vol. 17, n° 12, p. 845–850. doi: 10.1111/j.1365-2893.2009.01251.x
Fichiers principaux (1)
Article
Identifiants
- PID : unige:21309
- DOI : 10.1111/j.1365-2893.2009.01251.x
- PMID : 20070503
ISSN du journal1352-0504